Many bioentrepreneurs incorrectly estimate the value of their technology by failing to account adequately for the cost, risk, ...

PRNewswire/ -- ("Kos"), a global life sciences investment firm bridging the U.S. and European biopharma ecosystems, today ...

I would now like to turn the conference call over to Mariann Ohanesian, Senior Director of IR for Puma Biotechnology. You may ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable manufacturing platform capable of reshaping the future of food production through ...

T-cell engagers are designed to direct the body's immune system to recognize and attack cancer cells. Vir's PRO-XTEN technology is intended to keep these therapies inactive until they reach the tumor ...

Vir Biotechnology will host its third quarter 2026 financial results conference call at 4:30 p.m. ET / 1:30 p.m. PT today. A ...

Vir Biotechnology (VIR) has signed a collaboration and license agreement with Gilead focused on three PRO-XTEN dual-masked ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Researchers propose the Applied and Conservation Mycology Framework to align fungal biotechnology with Indigenous Knowledge ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001. What Are Smart Beta ...

<?xml encoding="utf-8" ?> Vir Biotechnology VIR reported third-quarter financial results on Wednesday. The transcript from ...